Publications by authors named "Mary Faber"

Claim this Profile
C
Cardiac dysfunction and altered gene expression in acid ceramidase-deficient mice.
Annie Kleynerman, Jitka Rybova, William M McKillop, Theresa A Dlugi, Mary L Faber

Am J Physiol Heart Circ Physiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma.
Mary Jo Rademacher, Mary L Faber, Kathleen M Bone, Jeffrey A Medin, Nathan J Schloemer

Exp Mol Pathol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice.
Xuejun Wang, William M McKillop, Theresa A Dlugi, Mary L Faber, Juliana Alvarez-Argote

J Gene Med· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel anti-CD30/CD3 bispecific antibodies activate human T cells and mediate potent anti-tumor activity.
Mary L Faber, Robyn A A Oldham, Archana Thakur, Mary Jo Rademacher, Ewa Kubicka

Front Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathophysiological characterization of the Townes mouse model for sickle cell disease.
Juliana Alvarez-Argote, Theresa A Dlugi, Teresa Sundararajan, Annie Kleynerman, Mary L Faber

Transl Res· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions.
Annie Kleynerman, Jitka Rybova, Mary L Faber, William M McKillop, Thierry Levade

Biomolecules· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous, lentivirus-modified, T-rapa cell "micropharmacies" for lysosomal storage disorders.
Murtaza S Nagree, Tania C Felizardo, Mary L Faber, Jitka Rybova, C Anthony Rupar

EMBO Mol Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sarcoma IL-12 overexpression facilitates NK cell immunomodulation.
Mary Jo Rademacher, Anahi Cruz, Mary Faber, Robyn A A Oldham, Dandan Wang

Sci Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and validation of surface -glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets.
Robyn A A Oldham, Mary L Faber, Theodore R Keppel, Amanda R Buchberger, Matthew Waas

J Immunother Cancer· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of the developing small intestine in the absence of either GATA4 or GATA6.
Emily M Walker, Cayla A Thompson, Bridget M Kohlnhofer, Mary L Faber, Michele A Battle

BMC Res Notes· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
E-cadherin is required for intestinal morphogenesis in the mouse.
Benjamin J Bondow, Mary L Faber, Kevin J Wojta, Emily M Walker, Michele A Battle

Dev Biol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis